MiNK Therapeutics Inc. (INKT)
NASDAQ: INKT
· Real-Time Price · USD
15.29
-0.03 (-0.20%)
At close: Aug 15, 2025, 3:59 PM
14.90
-2.55%
After-hours: Aug 15, 2025, 07:55 PM EDT
MiNK Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 3.23M | 4.58M | 6.33M | 9.31M | 5.82M | 3.37M | 6.4M | 10.62M | 14.89M | 19.64M | 24.16M | 29.85M | 34.69M | 38.89M | 819.45K | 1.66M | -2.69M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.38M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | n/a | n/a | n/a | n/a | -2.69M |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 23K | 35K | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.76K | 2.58M | 2.23M | n/a |
Other Current Assets | 108.71K | 164.24K | 11.2K | 61.14K | 122.48K | 177.96K | 29.34K | 166.03K | 320.89K | 470.3K | 37.52K | 378.13K | 604.64K | 721.32K | 2.57M | 2.37M | n/a |
Total Current Assets | 3.58M | 4.99M | 6.58M | 9.47M | 6M | 3.6M | 6.47M | 11.05M | 15.52M | 20.4M | 24.46M | 30.33M | 35.48M | 39.63M | 3.44M | 4.2M | 2.69M |
Property-Plant & Equipment | 687.5K | 732.93K | 799.52K | 849.96K | 894.99K | 953.98K | 991.46K | 1.06M | 1.07M | 1.07M | 803.13K | 787.54K | 665.21K | 606.6K | 635.89K | 552.48K | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 687.5K | 732.93K | 799.52K | 849.96K | 894.99K | 953.98K | 991.46K | 1.06M | 1.07M | 1.07M | 803.13K | 787.54K | 665.21K | 606.6K | 635.89K | 552.48K | -2.69M |
Total Assets | 4.27M | 5.72M | 7.37M | 10.32M | 6.89M | 4.55M | 7.46M | 12.11M | 16.59M | 21.47M | 25.26M | 31.12M | 36.14M | 40.24M | 4.08M | 4.75M | n/a |
Account Payables | 2.66M | 2.73M | 2.36M | 3.2M | 3.49M | 3.91M | 4.28M | 4.89M | 6M | 5.82M | 5.17M | 4.79M | 3.73M | 3M | 1.65M | 2.27M | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8.11M | 7.24M | n/a |
Short-Term Debt | 5.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 65.42M | 52.53M | n/a |
Other Current Liabilities | 2.37M | 2.36M | 2.39M | 6.94M | 2.34M | 5.66M | 2.27M | 2.33M | 2.49M | 5.21M | 10.44M | 9.79M | 12.45M | 12.89M | 10.4M | 10.3M | n/a |
Total Current Liabilities | 12.12M | 6.96M | 7.4M | 10.15M | 11.11M | 11.4M | 10.39M | 11.46M | 11.25M | 12.68M | 18.45M | 17.43M | 18.83M | 16.47M | 80.56M | 67.55M | n/a |
Long-Term Debt | n/a | 4.92M | 4.61M | 4.41M | 4.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 13.94M | 13.42M | 12.92M | 12.35M | 11.87M | 11.21M | 10.65M | 10.14M | 9.81M | 9.19M | 58.28K | n/a | n/a | n/a | 27.54K | 383.06K | n/a |
Total Long-Term Liabilities | 13.94M | 18.35M | 17.53M | 16.75M | 16.08M | 11.21M | 10.65M | 10.14M | 9.81M | 9.19M | 58.28K | 4.79M | 3.73M | 3M | 27.54K | 383.06K | n/a |
Total Liabilities | 26.06M | 25.31M | 24.93M | 26.9M | 27.19M | 22.61M | 21.04M | 21.61M | 21.06M | 21.87M | 18.51M | 17.43M | 18.83M | 16.47M | 80.59M | 67.93M | n/a |
Total Debt | 5.12M | 4.92M | 4.61M | 4.41M | 4.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 65.42M | 52.53M | n/a |
Common Stock | 40.00 | 40.00 | 395.00 | 394.00 | 347.00 | 346.00 | 345.00 | 345.00 | 343.00 | 339.00 | 338.00 | 337.00 | 336.00 | 335.00 | 242.00 | 242.00 | n/a |
Retained Earnings | -146.95M | -144.18M | -141.72M | -139.91M | -137.21M | -133.4M | -127.94M | -122.82M | -116.63M | -110.94M | -103.17M | -96.84M | -90.72M | -82.95M | -77.18M | -62.92M | n/a |
Comprehensive Income | -662.44K | -631.58K | -672.84K | -611.38K | -385.78K | -430.95K | -313.19K | -401.81K | -373.8K | -292.47K | -78.28K | 1.3M | -102.5K | -625.27K | -789.34K | -1.34M | -53.87M |
Shareholders Equity | -21.79M | -19.59M | -17.55M | -16.58M | -20.3M | -18.06M | -13.58M | -9.5M | -4.48M | -401.3K | 6.76M | 13.69M | 17.31M | 23.78M | -76.51M | -63.18M | -53.87M |
Total Investments | n/a | n/a | 6.32B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.38M |